2023 clinical immunization safety assessment (cisa) base IDIQ
Active Awarded Last action
- Contract number
- 75D30123D18247
- Awardee
-
The Trustees Of Columbia University In The City Of New York UEI QHF5ZZ114M72 Part of The Trustees Of Columbia University In The City Of New York
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Task orders
- 2 $992,335 obligated
Award facts
- Opportunity
-
- 75D30123R72855 Solicitation number
- Combined order value
-
- $997,435 Current, with exercised options
- $1,075,330 Potential, with all options
- Last date to order 62% complete
- IDV ceiling 1% used
- $86,008,000.12
- Maximum order
- $86,008,000.12
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 622110 General Medical and Surgical Hospitals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 10 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
Award details come from SAM.gov/FPDS.
About this IDV
The Centers for Disease Control and Prevention awarded a multiple-award indefinite delivery contract to The Trustees of Columbia University in the City of New York on September 25, 2023, with a ceiling value of $86,008,000 and performance through September 25, 2028. The 2023 Clinical Immunization Safety Assessment (CISA) contract carries no set-aside designation and supports vaccine safety monitoring and clinical immunization safety assessment services across CDC's vaccination surveillance and safety assessment initiatives.
Place of performance includes New York, New York and Durham, North Carolina, reflecting Columbia's Health Sciences Division operational footprint across multiple contributing sites.
The IDIQ funds clinical immunization safety assessment work, including respiratory syncytial virus infants study contributions and related vaccine safety monitoring activities. Performance is structured under a cost-no-fee pricing model.
Two delivery orders have been issued under this vehicle. The CDC issued a $300,905 delivery order on September 28, 2023, for clinical immunization safety assessment services with ultimate completion September 27, 2028, performed in New York. On September 27, 2024, the CDC issued a $774,425 delivery order for a respiratory syncytial virus infants study contributing site, ultimately due September 26, 2027, performed in Durham, North Carolina.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Cisa RSV infants study (contributing site) | CDC Pittsburgh | $767,661 | |
| 2023 clinical immunization safety assessment (cisa) base IDIQ | CDC Pittsburgh | $224,674 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75D30123D18247?
75D30123D18247 was awarded to The Trustees Of Columbia University In The City Of New York by CDC Pittsburgh (Centers for Disease Control and Prevention) on September 25, 2023.
How much is contract 75D30123D18247 worth?
Orders under 75D30123D18247 have obligated $992,335. Their combined current value, with exercised options, is $997,435. Their combined potential value, with all options, is $1,075,330. 75D30123D18247's own ceiling is $86,008,000. A single order can be worth up to $86,008,000.
How many orders have been placed under contract 75D30123D18247?
2 orders have been placed under 75D30123D18247, the latest on September 27, 2024.
Who can order from contract 75D30123D18247?
75D30123D18247 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75D30123D18247 part of a contract vehicle?
Yes. 75D30123D18247 is part of Clinical Immunization Safety Assessment 2023 - 2028 (CISA).
Was contract 75D30123D18247 competed?
The extent of competition for 75D30123D18247 was full and open competition. The government received 10 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV